VRDN Viridian Therapeutics, Inc.

NASDAQ

$20.47

Viridian Therapeutics, Inc. (VRDN) Earnings News

Earnings press releases, previews and reviews for Viridian Therapeutics, Inc. (VRDN), newest first.

Thursday August 6, 2026 7:01 AM ET

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Tuesday May 5, 2026 7:01 AM ET

Viridian Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Progress